ARCHIVES

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

Avon 1995 Grant Application Available

December 2, 1994

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

Hyperthermia, Radiation Enhancement, New Drugs Offer More Therapy Advances, ASCO Members Hear

April 7, 1978

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001